Literature DB >> 7762629

Stimulatory effect of bradykinin on insulin release from the perfused rat pancreas.

C Yang1, W H Hsu.   

Abstract

Rat pancreas perfusion was performed to study the effect of bradykinin on insulin release. At the perfusate glucose concentration of 6 mM, bradykinin (0.01-1 microM) increased insulin release in a concentration-dependent manner. In addition, bradykinin (1 microM) increased the glucose (10 mM)-induced insulin release. HOE-140 (0.1 microM), a bradykinin B2-receptor antagonist, decreased the baseline insulin release and abolished the bradykinin (1 microM)-induced increase in insulin release. In addition, HOE-140 (0.1 microM) attenuated the glucose (10 mM)-induced increase in insulin release. Because the blockade of bradykinin receptors by HOE-140 attenuated the glucose-induced increased insulin release, our present findings suggest that bradykinin may play a physiological role in the regulation of insulin release.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7762629     DOI: 10.1152/ajpendo.1995.268.5.E1027

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  5 in total

1.  Changes in blood glucose and plasma insulin levels induced by bradykinin in anaesthetized rats.

Authors:  J Damas; C Hallet; P J Lefebvre
Journal:  Br J Pharmacol       Date:  2001-11       Impact factor: 8.739

2.  An siRNA screen in pancreatic beta cells reveals a role for Gpr27 in insulin production.

Authors:  Gregory M Ku; Zachary Pappalardo; Chun Chieh Luo; Michael S German; Michael T McManus
Journal:  PLoS Genet       Date:  2012-01-12       Impact factor: 5.917

3.  BDKRB2 +9/-9 polymorphism is associated with higher risk for diabetes mellitus in the Brazilian general population.

Authors:  Rafael de Oliveira Alvim; Paulo C J L Santos; Raimundo M Nascimento; George L L M Coelho; José G Mill; José E Krieger; Alexandre C Pereira
Journal:  Exp Diabetes Res       Date:  2012-11-29

4.  Preclinical characterization of recombinant human tissue kallikrein-1 as a novel treatment for type 2 diabetes mellitus.

Authors:  Tadeusz Kolodka; Matthew L Charles; Arvind Raghavan; Ilian A Radichev; Christina Amatya; Jacob Ellefson; Alexei Y Savinov; Abhijeet Nag; Mark S Williams; Mark S Robbins
Journal:  PLoS One       Date:  2014-08-06       Impact factor: 3.240

5.  Thrombin stimulates insulin secretion via protease-activated receptor-3.

Authors:  Sonja Hänzelmann; Jinling Wang; Emre Güney; Yunzhao Tang; Enming Zhang; Annika S Axelsson; Hannah Nenonen; Albert S Salehi; Claes B Wollheim; Eva Zetterberg; Erik Berntorp; Ivan G Costa; Robert Castelo; Anders H Rosengren
Journal:  Islets       Date:  2015       Impact factor: 2.694

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.